Xtant Medical Holdings (XTNT) Restructuring Costs (2017 - 2018)
Xtant Medical Holdings (XTNT) posted quarterly Restructuring Costs of -$1.0 million for Q4 2018, down 130.88% year-over-year from $3.3 million in Q4 2017, and down 265.15% quarter-over-quarter from $614000.0 in Q3 2018.
Xtant Medical Holdings (XTNT) Restructuring Costs (2017 - 2018) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Restructuring Costs for 2 consecutive years, with -$1.0 million the latest figure, recorded in Q4 2018.
- In Q4 2018, Restructuring Costs fell 130.88% year-over-year to -$1.0 million; the TTM figure through Dec 2018 stood at $1.6 million (down 72.55% YoY), while the FY2018 annual figure was $1.6 million, down 66.5% from the prior year.
- Restructuring Costs retreated to -$1.0 million in Q4 2018 per XTNT's latest filing, from $614000.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $3.3 million in Q4 2017 and bottomed at -$1.0 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn |
| 10 | Xtant Medical Holdings | 46.73 Mn | 29.13 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -1.01 Mn |
| Sep 30, 2018 | 614,000.00 |
| Jun 30, 2018 | 1.23 Mn |
| Mar 31, 2018 | 733,000.00 |
| Dec 31, 2017 | 3.28 Mn |
| Sep 30, 2017 | 792,000.00 |
| Jun 30, 2017 | 1.63 Mn |